Clavulanic Acid Amoxicillin (Amoxi-Clav) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 28, 2026
Some Clavulanic Acid Amoxicillin products are in shortage in Canada (5 of 27 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 23, 2026.
An antibiotic combination used to treat bacterial infections such as ear, sinus, chest and urinary tract infections.
Products affected
5 / 27
In shortage since
Dec 23, 2024
Est. full return
Dec 23, 2026
Reports on file
77
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP AMOXI CLAV SUSPENSION
28.5MG
200MG · POWDER FOR SUSPENSION · JAMP PHARMA CORPORATION
DIN 02539411 · since Dec 23, 2024, est. end Dec 23, 2026 · Disruption of the manufacture of the drug.
Active shortage
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
200MG
2000MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02495937 · since Jun 22, 2026, est. end Aug 7, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
JAMP AMOXI CLAV SUSPENSION
57MG
400MG · POWDER FOR SUSPENSION · JAMP PHARMA CORPORATION
DIN 02539446 · since Jun 30, 2026, est. end Sep 25, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP AMOXI CLAV SUSPENSION
62.5MG
250MG · POWDER FOR SUSPENSION · JAMP PHARMA CORPORATION
DIN 02539438 · since Mar 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP AMOXI CLAV SUSPENSION
200MG
28.5MG · POWDER FOR SUSPENSION · JAMP PHARMA CORPORATION
DIN 02539411 · since Mar 12, 2026, est. end Dec 23, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-AMOXI CLAV
250MG
125MG · TABLET · APOTEX INC
DIN 02243350 · since Dec 2, 2025, est. end May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
200MG
2000MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02495937 · ended May 15, 2026 · Demand increase for the drug.
Resolved
JAMP AMOXI CLAV SUSPENSION
62.5MG
250MG · POWDER FOR SUSPENSION · JAMP PHARMA CORPORATION
DIN 02539438 · ended May 12, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP AMOXI CLAV
125MG
250MG · TABLET · JAMP PHARMA CORPORATION
DIN 02508249 · ended Apr 17, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP AMOXI CLAV
250MG
125MG · TABLET · JAMP PHARMA CORPORATION
DIN 02508249 · ended Apr 10, 2026 · Disruption of the manufacture of the drug.
Resolved
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
1000MG
200MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02495929 · ended Apr 6, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ AMOXI-CLAV TABLET
875MG
125MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02482584 · ended Nov 28, 2025 · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Clavulanic Acid Amoxicillin is currently affected by 5 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, SANDOZ CANADA INCORPORATED, APOTEX INC.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Clavulanic Acid Amoxicillin is classified under “BETA-LACTAM ANTIBACTERIALS, PENICILLINS” (ATC J01CR).
Recent changes
Jul 28, 2026
Estimated end date pushed back : Jul 10, 2026 → Dec 23, 2026
Jul 13, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
Common questions
What is Clavulanic Acid Amoxicillin used for?
An antibiotic combination used to treat bacterial infections such as ear, sinus, chest and urinary tract infections.
When will Clavulanic Acid Amoxicillin be back in stock in Canada?
The latest manufacturer estimate is Dec 23, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Clavulanic Acid Amoxicillin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.